Current issues in the treatment of schizophrenia

Professor Istvan Bitter from Semmelweis University, Budapest, Hungary is sharing his insights on schizophrenia treatment. In the last decades numerous second generation antipsychotics have been introduced. Considering efficacy and safety profiles, how can we personalize treatment? What is the treatment approach for patients with predominant negative symptoms? People with schizophrenia often die prematurely. What are the factors that contribute to this higher mortality rate?

Highlights of EPA 2023

Professor Peter Falkai, past president of the European Psychiatric Association, is sharing his insights on the EPA 2023 Congress, guided by the motto “Social Cohesion, a Common Goal for Psychiatry”. He discussed topics such as the role of loneliness in the development of mental illnesses, the impact of nutrition in the development and prevention of mental illness, as well as the most important novelties in the treatment of schizophrenia.